AKT1 and breast cancer: This finding provides confirmation that OSU-53 regulates the EMT of breast cancer cells by targeting AKT-murine double minute 2 (MDM2), thereby promoting the activation of FOXO3a, which further validating OSU-53’s anti-EMT activity was mediated by FOXO3a (Chou et al., 2014).